Evotec, UoB To Expand Molecular Patient Database In Kidney Diseases With Nephrotic Syndrome
1/3 07:56
(RTTNews) - Evotec AG (EVTCY.PK), a German drug discovery and development company, Tuesday said that it has entered into a collaboration with the University of Bristol or UoB to expand molecular patient database in the field of kidney diseases with a focus on nephrotic syndrome....